These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 24633923)

  • 1. Diphenhydramine has similar interspecies net active influx at the blood-brain barrier.
    Shaffer CL; Osgood SM; Mancuso JY; Doran AC
    J Pharm Sci; 2014 May; 103(5):1557-62. PubMed ID: 24633923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations.
    Doran AC; Osgood SM; Mancuso JY; Shaffer CL
    Drug Metab Dispos; 2012 Nov; 40(11):2162-73. PubMed ID: 22899853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative projection of human brain penetration of the H
    Sawant-Basak A; Chen L; Shaffer CL; Palumbo D; Schmidt A; Tseng E; Spracklin DK; Gallezot JD; Labaree D; Nabulsi N; Huang Y; Carson RE; McCarthy T
    Xenobiotica; 2017 Feb; 47(2):119-126. PubMed ID: 27353353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(-/-) rats.
    Nagaya Y; Nozaki Y; Takenaka O; Watari R; Kusano K; Yoshimura T; Kusuhara H
    Drug Metab Pharmacokinet; 2016 Feb; 31(1):57-66. PubMed ID: 26830080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics.
    Boström E; Simonsson US; Hammarlund-Udenaes M
    Drug Metab Dispos; 2006 Sep; 34(9):1624-31. PubMed ID: 16763013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphenhydramine active uptake at the blood-brain barrier and its interaction with oxycodone in vitro and in vivo.
    Sadiq MW; Borgs A; Okura T; Shimomura K; Kato S; Deguchi Y; Jansson B; Björkman S; Terasaki T; Hammarlund-Udenaes M
    J Pharm Sci; 2011 Sep; 100(9):3912-23. PubMed ID: 21472729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacokinetic study of diphenhydramine transport across the blood-brain barrier in adult sheep: potential involvement of a carrier-mediated mechanism.
    Au-Yeung SC; Rurak DW; Gruber N; Riggs KW
    Drug Metab Dispos; 2006 Jun; 34(6):955-60. PubMed ID: 16510542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Human Brain Penetration of P-glycoprotein and Breast Cancer Resistance Protein Substrates Using In Vitro Transporter Studies and Animal Models.
    Feng B; Doran AC; Di L; West MA; Osgood SM; Mancuso JY; Shaffer CL; Tremaine L; Liras J
    J Pharm Sci; 2018 Aug; 107(8):2225-2235. PubMed ID: 29608887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Quantitative Understanding of PEGylated Liposome's Influence on Brain Delivery of Diphenhydramine.
    Hu Y; Gaillard PJ; Rip J; de Lange ECM; Hammarlund-Udenaes M
    Mol Pharm; 2018 Dec; 15(12):5493-5500. PubMed ID: 30376346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined PET and microdialysis for in vivo estimation of drug blood-brain barrier transport and brain unbound concentrations.
    Gustafsson S; Eriksson J; Syvänen S; Eriksson O; Hammarlund-Udenaes M; Antoni G
    Neuroimage; 2017 Jul; 155():177-186. PubMed ID: 28467891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier transport helps to explain discrepancies in in vivo potency between oxycodone and morphine.
    Boström E; Hammarlund-Udenaes M; Simonsson US
    Anesthesiology; 2008 Mar; 108(3):495-505. PubMed ID: 18292687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of microdialysis for the study of drug kinetics: central nervous system pharmacokinetics of diphenhydramine in fetal, newborn, and adult sheep.
    Au-Yeung SC; Riggs KW; Gruber N; Rurak DW
    Drug Metab Dispos; 2007 Aug; 35(8):1285-91. PubMed ID: 17485495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropharmacokinetics of a new alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) modulator, S18986 [(S)-2,3-dihydro-[3,4]cyclopentano-1,2,4-benzothiadiazine-1,1-dioxide], in the rat.
    Bourasset F; Bernard K; Muñoz C; Genissel P; Scherrmann JM
    Drug Metab Dispos; 2005 Aug; 33(8):1137-43. PubMed ID: 15860654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative evaluation of brain distribution and blood-brain barrier efflux transport of probenecid in rats by microdialysis: possible involvement of the monocarboxylic acid transport system.
    Deguchi Y; Nozawa K; Yamada S; Yokoyama Y; Kimura R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):551-60. PubMed ID: 9023263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Rat Plasma and Brain Extracellular Fluid Pharmacokinetic Model for Bupropion and Hydroxybupropion Based on Microdialysis Sampling, and Application to Predict Human Brain Concentrations.
    Cremers TI; Flik G; Folgering JH; Rollema H; Stratford RE
    Drug Metab Dispos; 2016 May; 44(5):624-33. PubMed ID: 26916207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study.
    Bällgren F; Hammarlund-Udenaes M; Loryan I
    Pharm Res; 2023 Nov; 40(11):2715-2730. PubMed ID: 37610619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic modelling of blood-brain barrier transport of escitalopram in rats.
    Bundgaard C; Jørgensen M; Larsen F
    Biopharm Drug Dispos; 2007 Oct; 28(7):349-60. PubMed ID: 17654695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxymorphone active uptake at the blood-brain barrier and population modeling of its pharmacokinetic-pharmacodynamic relationship.
    Sadiq MW; Boström E; Keizer R; Björkman S; Hammarlund-Udenaes M
    J Pharm Sci; 2013 Sep; 102(9):3320-31. PubMed ID: 23463542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing ketamine translational pharmacology via receptor occupancy normalization.
    Shaffer CL; Osgood SM; Smith DL; Liu J; Trapa PE
    Neuropharmacology; 2014 Nov; 86():174-80. PubMed ID: 25063581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The blood-brain barrier transport mechanism controlling analgesic effects of opioid drugs in CNS].
    Okura T; Higuchi K; Deguchi Y
    Yakugaku Zasshi; 2015; 135(5):697-702. PubMed ID: 25948304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.